As shown in Figure 1 and Figure 2, immunohistochemical expression of IL13Rα2 was highly associated with cancer-specific survival and relapse-free survival by univariate and multivariate analysis in 229 RCC patients. The gene discussed is IL13RA2; the disease is cancer.